sentibio.com (SNTI): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Logo perusahaan publik Senti Biosciences (SNTI)

Senti Biosciences, Inc. (SNTI) relies on a team of leading geneticists developing AI circuits to combat cancer. The projected earnings per share (EPS) for year n+1 visualizes this potential, where 0.00 represents the latest level value. Growth is supported by biochip patents attracting pharma behemoths, while a digital database of genetic codes ensures scalability and superprofits from global licenses.

Senti Biosciences, Inc. (SNTI): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 28.04.2023 nganti 13.11.2026

Ringkesan rincian data analitis Senti Biosciences (SNTI)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:SNTI, Senti Biosciences, Inc.
Produk dadi Senti Biosciences

This indicator aggregates expert estimates of profit dynamics for the coming year, measuring the market consensus regarding net income growth rates. The metric's values react sharply to operational updates, reflecting a revision of the asset's fundamental value. The EPS forecast trend for Senti Biosciences, Inc. (SNTI) on GURU.Markets demonstrates how the diversification of Senti Biosciences, Inc. (SNTI) gene programs and partnerships with pharma behemoths minimize risks, stabilizing investor expectations.